Enrique Quintero in Houston, Texas

Medical School: Sorry, his university is not listed
Graduation Year: 1984
The Primary Medical Specialty for Enrique Quintero is listed as: Allergy/immunology
Approximate Years of Experience: 40
PAC (PECOS ID)#: 6800991431
NPI #: 1265439855
NPI Created On: 06/28/2005
NPI Last Updated Listed as: 08/26/2015
Primary Taxonomy Code: 207K00000X
License Number:
H2704
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Community Health Choice
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Removal of impact ear wax, one ear
2. Ct scan of face
3. Air and bone conduction assessment of hearing loss and speech recognition
4. Eardrum testing using ear probe
5. Measurement and graphic recording of total and timed exhaled air capacity
6. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
7. Diagnostic testing in a pulmonary function lab
8. Injection of allergenic extracts into skin, accessed through the skin
9. Injection of allergenic extracts into skin for immediate reaction analysis
10. Injection of incremental dosages of allergen
11. Injection of incremental dosages of allergen, 2 or more injections
12. Preparation and provision of single or multiple antigens for allergen immunotherapy
13. New patient office or other outpatient visit, typically 30 minutes
14. New patient office or other outpatient visit, typically 45 minutes
15. New patient office or other outpatient visit, typically 60 minutes
16. Established patient office or other outpatient visit, typically 5 minutes
17. Established patient office or other outpatient visit, typically 15 minutes
18. Established patient office or other outpatient, visit typically 25 minutes
19. Established patient office or other outpatient, visit typically 40 minutes
20. Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg